SCHEMBL12465744

SCHEMBL12465744

CCC(=O)C(CC(=O)c1ccc2c(c1)C(C)(C)CCN2C(C)=O)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.41
RARA P10276 5/20 0.41
ALDH1A1 P00352 5/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
RECQL P46063 1/20 0.39
RARG P13631 3/20 0.39
MAPT P10636 3/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.36
NOTUM Q6P988 4/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
PKM P14618 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
CRBN Q96SW2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12465600 0.92 RARB (0.41) RARBRARAALDH1A1HPGDKDM4E
SCHEMBL12465855 0.82 RARB (0.44) RARBRARAALDH1A1HPGDKDM4E
SCHEMBL12465787 0.79 HDAC1 (0.47) RARBRARAALDH1A1HPGDRARG
SCHEMBL10558185 0.78 NOTUM (0.44) RARBRARARARGMAPTNOTUM
SCHEMBL15388709 0.76 RARB (0.50) RARBRARAHPGDRARGHDAC1
SCHEMBL12465677 0.75 MCHR1 (0.32) NOTUM
SCHEMBL12465617 0.72 RARB (0.41) RARBRARAALDH1A1HPGDKDM4E
SCHEMBL12465927 0.72 MCHR1 (0.33) ALDH1A1HPGDKDM4ERECQLMAPT
SCHEMBL15388932 0.72 HDAC6 (0.45) RARBALDH1A1RARGMAPTHDAC1
SCHEMBL12466110 0.70 RARB (0.47) RARBRARAALDH1A1RARGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670744-B1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LTD (IN) 2015-05-27 EP disclosed
EP-2670744-B1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LTD (IN) 2015-05-27 EP disclosed
EP-2670744-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR Lupin Limited (IN) 2013-12-11 EP disclosed
US-20130310419-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LIMITED (IN) 2013-11-21 US disclosed
US-20130310419-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LIMITED (IN) 2013-11-21 US disclosed
WO-2012104782-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LIMITED (IN) 2012-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130310419-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR CHRNA7, CHRNE, CHRNA5 RARB 1245/4885RARA 1083/4885ALDH1A1 2246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.